Poster 19
- Jun 16, 2023
- 1 min read
Flare-Free Disease Control Up to 3 Years Following Lebrikizumab Treatment in Atopic Dermatitis Patients Achieving 16-Week Response: A Post-Hoc Analysis of the ADjoin Study
Joseph Merola, Leon Kircik, Sebastien Barbarot, Jose Manuel Carrascosa, Stephan Weidinger, Peter Lio, Francis Corrado, Gaia Gallo, Yuxin Ding, Yi Li, Helena Agell, Jonathan I Silverberg


